Sorrento Therapeutics, Inc. Share Price
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Markets
16/09/2026
|
5-day change | 1st Jan Change | ||
| 0.000400 USD | 0.00% |
|
-20.00% | -84.62% |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 58.19M 55M 49.93M 93.58M 6.44B 94.14M 657M 254M 3.27B 252M 247M 10.41B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 131M 124M 113M 211M 14.55B 213M 1.48B 573M 7.38B 570M 557M 23.52B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 week | -20.00% | ||
| Current month | -20.00% | ||
| 1 month | -42.86% | ||
| 3 months | -42.86% | ||
| 6 months | -87.50% | ||
| Current year | -84.62% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.05 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 8.22 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 31/03/2011 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/2022 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 31/07/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -20.00% | -92.45% | -99.81% | 217K | |
| +0.66% | +0.87% | +47.39% | +97.63% | 69.18B | |
| -1.19% | -1.92% | +34.57% | +73.08% | 62B | |
| +2.22% | -4.83% | -15.32% | +360.65% | 26.19B | |
| +1.46% | +1.30% | +28.58% | +13.76% | 25.75B | |
| -0.89% | -2.34% | -3.46% | -15.24% | 24.29B | |
| +2.84% | +2.12% | +24.28% | -17.13% | 19.84B | |
| 0.00% | -14.23% | +170.04% | +298.75% | 15.65B | |
| -0.57% | -1.37% | -4.53% | +825.13% | 13.88B | |
| -0.39% | -5.61% | -9.51% | +483.04% | 14.09B | |
| Average | +0.41% | -1.71% | +17.96% | +201.99% | 27.09B | |
| Weighted average by Cap. | +0.33% | -0.98% | +31.82% | +159.89% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 45.85M 43.33M 39.34M 73.73M 5.08B 74.17M 517M 200M 2.57B 199M 194M 8.21B | 62.84M 54.46M 51.47M 46.73M 87.58M 6.03B 88.1M 614M 237M 3.06B 236M 231M 9.75B |
| Net income | -428M -371M -351M -319M -597M -41.09B -601M -4.19B -1.62B -20.84B -1.61B -1.57B -66.43B | -573M -496M -469M -426M -798M -54.95B -803M -5.6B -2.16B -27.87B -2.15B -2.1B -88.84B |
| Net Debt | 111M 95.93M 90.67M 82.31M 154M 10.62B 155M 1.08B 418M 5.39B 416M 407M 17.17B | 84.53M 73.25M 69.23M 62.85M 118M 8.11B 119M 827M 319M 4.11B 318M 310M 13.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | US$0.000400 | 0.00% | 79,548 |
| 15/09/26 | US$0.000400 | 0.00% | 88,787 |
| 14/09/26 | US$0.000400 | 0.00% | 64,522 |
| 11/09/26 | US$0.000400 | 0.00% | 73,281 |
| 10/09/26 | US$0.000400 | -20.00% | 33,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Select your edition
All financial news and data tailored to specific country editions
